D. Boumpas

1.2k total citations
17 papers, 871 citations indexed

About

D. Boumpas is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, D. Boumpas has authored 17 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 6 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in D. Boumpas's work include Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). D. Boumpas is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). D. Boumpas collaborates with scholars based in Greece, United States and France. D. Boumpas's co-authors include H Kritikos, Helen Α. Papadaki, George D. Eliopoulos, Prodromos Sidiropoulos, Judith Marsh, Dionysios E. Kyrmizakis, Amalia Raptopoulou, Dimitrios Tsetis, E. C. Gordon‐Smith and David Jayne and has published in prestigious journals such as Annals of Internal Medicine, Annals of the Rheumatic Diseases and British Journal of Haematology.

In The Last Decade

D. Boumpas

17 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Boumpas Greece 9 514 246 163 146 137 17 871
Kyriaki Boki Greece 21 761 1.5× 347 1.4× 97 0.6× 150 1.0× 273 2.0× 54 1.2k
J.E. Gottenberg France 14 662 1.3× 362 1.5× 177 1.1× 59 0.4× 108 0.8× 34 1.4k
Francesca Bellisai Italy 21 611 1.2× 313 1.3× 54 0.3× 87 0.6× 200 1.5× 62 1.1k
Francesca Pregnolato Italy 21 850 1.7× 266 1.1× 103 0.6× 278 1.9× 104 0.8× 48 1.3k
Micaela Fredi Italy 25 1.1k 2.2× 610 2.5× 61 0.4× 124 0.8× 110 0.8× 89 1.7k
Stefania Sacco Italy 13 502 1.0× 264 1.1× 211 1.3× 42 0.3× 69 0.5× 20 958
H. Englert Australia 20 631 1.2× 260 1.1× 43 0.3× 102 0.7× 113 0.8× 41 1.3k
Park Yb South Korea 16 327 0.6× 203 0.8× 69 0.4× 131 0.9× 305 2.2× 32 903
Alojzija Hočevar Slovenia 20 551 1.1× 131 0.5× 174 1.1× 152 1.0× 595 4.3× 87 1.2k
R. Valente United States 14 828 1.6× 307 1.2× 289 1.8× 57 0.4× 346 2.5× 25 1.3k

Countries citing papers authored by D. Boumpas

Since Specialization
Citations

This map shows the geographic impact of D. Boumpas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Boumpas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Boumpas more than expected).

Fields of papers citing papers by D. Boumpas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Boumpas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Boumpas. The network helps show where D. Boumpas may publish in the future.

Co-authorship network of co-authors of D. Boumpas

This figure shows the co-authorship network connecting the top 25 collaborators of D. Boumpas. A scholar is included among the top collaborators of D. Boumpas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Boumpas. D. Boumpas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ιωάννου, Μαριάννα, et al.. (2015). AB0175 Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Due to Ros-Dependent Extracellular Trap Formation. Annals of the Rheumatic Diseases. 74. 949–949. 1 indexed citations
2.
Mashreghi, Mir‐Farzin, Helen Latsoudis, Joachim Gruen, et al.. (2014). THU0467 Silencing of the MEFV Gene in Familial Mediterranean Fever and Transcriptomic Analysis in Human Monocytes: Evidence for the Involvement of Pyrin in Innate Immune Responses and Autophagy. Annals of the Rheumatic Diseases. 73. 344–345. 1 indexed citations
3.
4.
Nüßlein, H., Rieke Alten, M. Galeazzi, et al.. (2012). AB0531 Real-world efficacy and safety of abatacept treatment for RA: 12-month interim analysis of the action study. Annals of the Rheumatic Diseases. 71. 668–668. 5 indexed citations
5.
Nüßlein, H., Rieke Alten, M. Galeazzi, et al.. (2012). AB0532 Effect of prior therapy on the efficacy and safety of abatacept: 6-month analysis of the action study. Annals of the Rheumatic Diseases. 71. 668–668. 2 indexed citations
6.
Βertsias, George, Clio P. Mavragani, H Kritikos, et al.. (2010). Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece.. PubMed. 27(1 Suppl 52). S33–9. 48 indexed citations
7.
Sidiropoulos, Prodromos, et al.. (2008). Sustained improvement of vascular endothelial function during anti‐TNFα treatment in rheumatoid arthritis patients. Scandinavian Journal of Rheumatology. 38(1). 6–10. 72 indexed citations
8.
9.
Sidiropoulos, Páris, Stéphane Roche, Jochen Ringe, et al.. (2007). Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(6). 741–749. 129 indexed citations
10.
Sidiropoulos, Prodromos, et al.. (2005). Low dose of infliximab is inadequate in most patients with spondylarthropathies.. PubMed. 23(4). 513–6. 25 indexed citations
11.
Papadimitraki, Eva D., et al.. (2004). Ear-nose-throat manifestations of autoimmune rheumatic diseases.. PubMed. 22(4). 485–94. 40 indexed citations
12.
Papadaki, Helen Α., et al.. (2002). Non-Hodgkin's Lymphoma in Patients with Systemic Lupus Erythematosus. Leukemia & lymphoma. 44(2). 275–279. 4 indexed citations
13.
Papadaki, Helen Α., D. Boumpas, Frances M. Gibson, et al.. (2001). Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. British Journal of Haematology. 115(1). 167–174. 77 indexed citations
14.
Danning, Carol L. & D. Boumpas. (1998). Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of action.. PubMed. 16(5). 595–604. 16 indexed citations
15.
Boumpas, D., et al.. (1993). Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy. Annals of Internal Medicine. 119(5). 366–369. 363 indexed citations
16.
Boumpas, D., et al.. (1990). C‐MYC proto‐oncogene expression in peripheral blood mononuclear cells from patients with primary Sjögren's syndrome. Arthritis & Rheumatism. 33(1). 49–56. 8 indexed citations
17.
Boumpas, D., et al.. (1990). Intermittent Cyclophosphamide for the Treatment of Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus. Annals of Internal Medicine. 112(9). 674–677. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyriaki Boki Breakdown of academic impact, for papers by J.E. Gottenberg Breakdown of academic impact, for papers by Francesca Bellisai Breakdown of academic impact, for papers by Francesca Pregnolato Breakdown of academic impact, for papers by Micaela Fredi Breakdown of academic impact, for papers by Stefania Sacco Breakdown of academic impact, for papers by H. Englert Breakdown of academic impact, for papers by Park Yb Breakdown of academic impact, for papers by Alojzija Hočevar Breakdown of academic impact, for papers by R. Valente
Rankless by CCL
2026